In February 2021, Chinese guidelines for diagnosis and treatment of diabetic kidney disease (Registration number: IPGRP-2021CN035) were published online by the Chinese Society of Nephrology in the Chinese Journal of Nephrology. The guideline is based on domestic and international expert consensus and integrates the clinical experience of Chinese nephrologists. This guideline contains the diagnosis of diabetic kidney disease (DKD), renal pathology biopsy, treatment and management, management of complications, and rational application of commonly used drugs. The expert group has referred to the international guideline format in the preparation process based on the principles of rigor, conciseness, and authority. The guidelines reflect new trends and perspectives in the treatment of DKD and are of great value in further strengthening the understanding of DKD, standardizing the treatment system, formulating reasonable treatment principles, guiding the precise use of drugs, delaying the progression of kidney disease. It will improve the life quality of patients and could be used by physicians for reference in clinical work.
The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement, published in 2009, was designed to help to improve the reporting quality of the systematic reviews. The first edition of the PRISMA statement has been published over 10 years. Over the past decade, advances in systematic review methodology and terminology have necessitated an update to the guideline.
The RIGHT Extension Statement for Traditional Chinese Medicine: Development, Recommendations, and ExplanationIn January 2021，Runsheng Xie published an article in Pharmacological Research entitled The RIGHT Extension Statement for Traditional Chinese Medicine: Development, Recommendations, and Explanation. Nowadays, the number of traditional Chinese medicine (TCM) guidelines is constantly increasing, but its reporting quality remains unsatisfactory. The group hopes that the RIGHT-TCM may assist TCM guideline developers in reporting guidelines, support journal editors and peer reviewers when considering TCM guideline reports, and help health care practitioners understand and implement a TCM guideline.
Clinical practice guideline registration: toward reducing duplication, improving collaboration, and increasing transparencyRegistration is a way for researchers to provide key features from their protocol and results which are recorded and published progressively through an online and open platform. In 2007, the International Clinical Trial Registry Platform (ICTRP) based at the World Health Organization (WHO) was established, enabling the full implementation of the clinical trial registry. In 2011, an International Prospective Register of Systematic Reviews (PROSPERO) was developed, so that registration of systematic reviews/Meta-analysis was gradually recognized and applied. Compared with the clinical trials and systematic reviews, clinical practice guidelines (CPGs) are important guidance documents for medical practice. However, prospective registration for CPGs has become relatively late with lacking attention for its importance and significance. The concept, methods and approaches of registration for CPGs have also not been fully discussed by researchers, guideline developers and journal editors for a long time.
The methodological quality in clinical practice guidelines in the context of COVID-19 needs to be improvedIn March 7, 2021, Tanja A Stamm, et al published an article entitled “The methodological quality is insufficient in clinical practice guidelines in the context of COVID-19: systematic review” in the Journal of Clinical Epidemiology. This study systematic searched clinical practice guidelines or recommendations related to Corona Virus Disease 2019 (COVID-19), and assessed their methodological quality by using the Appraisal of Guidelines for Research and Evaluation II (AGREE II) tool.
Published Online: guidelines for the diagnosis, treatment and prevention of COVID-19 in adults in ChinaIn February 2021, “中国成人2019冠状病毒病的诊治与防控指南(Guidelines for the diagnosis, treatment and prevention of COVID-19 in adults in China)” (IPGRP-2020CN187) was published online by Chinese Thoracic Society (CTS) and Chinese Association of Chest Physicians (CACP) in Chinese Medical Journal.
In January 2021，Xiaoqin Wang published an article in Implementation Science entitled “The reporting checklist for public versions of guidelines: RIGHT-PVG”.
Supporting effective participation in health guideline development groups: The Guideline Participant ToolIn September 2020, Thomas Piggott published an article in the Journal of Clinical Epidemiology entitled “Supporting effective participation in health guideline development groups: The Guideline Participant Tool” (https://www.jclinepi.com/article/S0895-4356(20)31100-8/fulltext). Effective participation in guideline development groups or development groups is crucial for guideline success, yet little guidance exists for members of these groups. The article pointed out that the Guideline Participant Tool (GPT) support effective participation in guideline groups, in particular those using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach.
September 30, 2020, a review article entitled Developing trustworthy recommendations as part of an urgent response (1-2 weeks): a GRADE concept paper GRADE Rapid Guidelines project group was published in the Journal of Clinical Epidemiology. This article drafted by the GRADE Rapid Guidelines project group and proposed an approach for developing trustworthy recommendations as part of urgent responses (1-2 weeks) in the clinical, public health, and health systems fields.
Cochrane, JBI, Campbell Collaboration and Guidelines International Network announced the host of the Global Evidence Summit (GES) 2021 is the Czech National Centre for Evidence-Based Healthcare and Knowledge Translation (CEBHCKT).